Laurus Labs Q3 profits surge 388% with ₹1,000 cr CAPEX plan
pre-market1 source ↓written by the desknot a recommendation
- Labs reported
- 388% surge in PAT
- for Q3 FY'26
- ₹610 cr
- Revenue reached
- ₹1,778 cr
- to fuel future
- ₹1,000 cr CAPEX
Laurus Labs reported a 388% surge in PAT to ₹610 cr for Q3 FY'26, driven by strong performance in its Generics and CDMO segments. Revenue reached ₹1,778 cr, with EBITDA margins expanding to over 27%. The company plans a ₹1,000 cr CAPEX to fuel future growth. 📈
Not investment advice. For informational purposes only.